标题
CNS-targeting pharmacological interventions for the metabolic syndrome
作者
关键词
-
出版物
JOURNAL OF CLINICAL INVESTIGATION
Volume 129, Issue 10, Pages 4058-4071
出版商
American Society for Clinical Investigation
发表日期
2019-08-05
DOI
10.1172/jci129195
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans
- (2019) Satish Patel et al. Cell Metabolism
- Melanocortin-4 Receptor Signalling: Importance for Weight Regulation and Obesity Treatment
- (2019) Peter Kühnen et al. TRENDS IN MOLECULAR MEDICINE
- Activation of Agrp neurons modulates memory-related cognitive processes in mice
- (2019) Marcelo R. Zimmer et al. PHARMACOLOGICAL RESEARCH
- IL1R1 is required for celastrol’s leptin-sensitization and antiobesity effects
- (2019) Xudong Feng et al. NATURE MEDICINE
- The Hypothalamic Arcuate Nucleus-Median Eminence is a Target for Sustained Diabetes Remission Induced by Fibroblast Growth Factor 1
- (2019) Jenny M. Brown et al. DIABETES
- A GLP-1:CCK fusion peptide harnesses the synergistic effects on metabolism of CCK-1 and GLP-1 receptor agonism in mice
- (2018) David C. Hornigold et al. APPETITE
- Obesity
- (2018) Kishore M. Gadde et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study
- (2018) Philip Ambery et al. LANCET
- MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency
- (2018) Karine Clément et al. NATURE MEDICINE
- Gut hormone polyagonists for the treatment of type 2 diabetes
- (2018) Sara J. Brandt et al. PEPTIDES
- How and why do gastrointestinal peptides influence food intake?
- (2018) Stephen C. Woods et al. PHYSIOLOGY & BEHAVIOR
- Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
- (2018) Richard E Pratley et al. Lancet Diabetes & Endocrinology
- Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis
- (2018) M Angelyn Bethel et al. Lancet Diabetes & Endocrinology
- The Ascending GLP-1 Road From Clinical Safety to Reduction of Cardiovascular Complications
- (2018) Daniel J. Drucker DIABETES
- Celastrol Induced Weight Loss is Driven by Hypophagia and Independent From UCP1
- (2018) Katrin Pfuhlmann et al. DIABETES
- A novel dual glucagon-like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo-controlled first-in-human and first-in-patient trials
- (2018) Joachim Tillner et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
- (2018) Patrick M O'Neil et al. LANCET
- Genetic identification of leptin neural circuits in energy and glucose homeostases
- (2018) Jie Xu et al. NATURE
- Fluorescent blood–brain barrier tracing shows intact leptin transport in obese mice
- (2018) Luke Harrison et al. INTERNATIONAL JOURNAL OF OBESITY
- Celastrol Promotes Weight Loss in Diet-Induced Obesity by Inhibiting the Protein Tyrosine Phosphatases PTP1B and TCPTP in the Hypothalamus
- (2018) Eleni Kyriakou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial
- (2018) Juan Pablo Frias et al. LANCET
- Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial
- (2018) Erin A Bohula et al. LANCET
- Role of astrocytes, microglia, and tanycytes in brain control of systemic metabolism
- (2018) Cristina García-Cáceres et al. NATURE NEUROSCIENCE
- Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models
- (2018) Elizabeth A. Killion et al. Science Translational Medicine
- Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism
- (2018) Piotr A. Mroz et al. Molecular Metabolism
- Targeted delivery of antisense oligonucleotides to pancreatic β-cells
- (2018) C. Ämmälä et al. Science Advances
- Blaming the Brain for Obesity: Integration of Hedonic and Homeostatic Mechanisms
- (2017) Hans-Rudolf Berthoud et al. GASTROENTEROLOGY
- Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes
- (2017) Melanie Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A potent, selective, and orally bioavailable inhibitor of the protein-tyrosine phosphatase PTP1B improves insulin and leptin signaling in animal models
- (2017) Navasona Krishnan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand
- (2017) Linda Yang et al. NATURE MEDICINE
- GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates
- (2017) Shannon E Mullican et al. NATURE MEDICINE
- The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL
- (2017) Paul J Emmerson et al. NATURE MEDICINE
- Evolution of physicochemical properties of melanin concentrating hormone receptor 1 (MCHr1) antagonists
- (2016) Anders Johansson BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity
- (2016) Faidon Magkos et al. Cell Metabolism
- A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients
- (2016) Mirna S. Abd El Aziz et al. DIABETES OBESITY & METABOLISM
- Renaissance of leptin for obesity therapy
- (2016) Carmelo Quarta et al. DIABETOLOGIA
- Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents
- (2016) Jarrad M Scarlett et al. NATURE MEDICINE
- Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice
- (2016) Jaemin Lee et al. NATURE MEDICINE
- Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist
- (2016) Peter Kühnen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of Obesity with Celastrol
- (2015) Junli Liu et al. CELL
- Hypothalamic Agrp Neurons Drive Stereotypic Behaviors beyond Feeding
- (2015) Marcelo O. Dietrich et al. CELL
- Diet-Induced Obese Mice Retain Endogenous Leptin Action
- (2015) Nickki Ottaway et al. Cell Metabolism
- Neuronal Regulation of Energy Homeostasis: Beyond the Hypothalamus and Feeding
- (2015) Michael J. Waterson et al. Cell Metabolism
- Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
- (2015) Jesper Lau et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed mice
- (2015) V. Pathak et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The anti-diabetic effects of GLP-1-gastrin dual agonist ZP3022 in ZDF rats
- (2015) Jolanta Skarbaliene et al. PEPTIDES
- AgRP Neurons Regulate Bone Mass
- (2015) Jae Geun Kim et al. Cell Reports
- Meteorin-like Is a Hormone that Regulates Immune-Adipose Interactions to Increase Beige Fat Thermogenesis
- (2014) Rajesh R. Rao et al. CELL
- O-GlcNAc Transferase Enables AgRP Neurons to Suppress Browning of White Fat
- (2014) Hai-Bin Ruan et al. CELL
- Adipsin Is an Adipokine that Improves β Cell Function in Diabetes
- (2014) James C. Lo et al. CELL
- GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice
- (2014) Robert W. Schwenk et al. DIABETOLOGIA
- The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
- (2014) Anna Secher et al. JOURNAL OF CLINICAL INVESTIGATION
- Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
- (2014) Kathleen M Dungan et al. LANCET
- A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
- (2014) Brian Finan et al. NATURE MEDICINE
- Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study
- (2014) Richard E Pratley et al. Lancet Diabetes & Endocrinology
- GLP-1 receptor agonists: a review of head-to-head clinical studies
- (2014) Jennifer M. Trujillo et al. Therapeutic Advances in Endocrinology and Metabolism
- The insulin sensitizing effect of topiramate involves KATPchannel activation in the central nervous system
- (2013) C P Coomans et al. BRITISH JOURNAL OF PHARMACOLOGY
- GLP-1/Glucagon Coagonism Restores Leptin Responsiveness in Obese Mice Chronically Maintained on an Obesogenic Diet
- (2013) C. Clemmensen et al. DIABETES
- Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin: A 24-week, randomized, open-label, active-controlled study (GetGoal-X)
- (2013) J. Rosenstock et al. DIABETES CARE
- Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
- (2013) P. Hollander et al. DIABETES CARE
- A novel long-acting glucose-dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodents
- (2013) K. Tatarkiewicz et al. DIABETES OBESITY & METABOLISM
- Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis
- (2013) Eric D. Berglund et al. JOURNAL OF CLINICAL INVESTIGATION
- Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults
- (2013) Louis J. Aronne et al. Obesity
- Eight-year weight losses with an intensive lifestyle intervention: The look AHEAD study
- (2013) Obesity
- Improved Glucose Control and Reduced Body Weight in Rodents with Dual Mechanism of Action Peptide Hybrids
- (2013) James L. Trevaskis et al. PLoS One
- Effects of lixisenatide once daily on gastric emptying in type 2 diabetes — Relationship to postprandial glycemia
- (2013) Martin Lorenz et al. REGULATORY PEPTIDES
- Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
- (2013) B. Finan et al. Science Translational Medicine
- Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21
- (2012) Timo D. Müller et al. JOURNAL OF PEPTIDE SCIENCE
- Neutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity
- (2012) F J Meye et al. MOLECULAR PSYCHIATRY
- A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
- (2012) Pontus Boström et al. NATURE
- Targeted estrogen delivery reverses the metabolic syndrome
- (2012) Brian Finan et al. NATURE MEDICINE
- AgRP neurons regulate development of dopamine neuronal plasticity and nonfood-associated behaviors
- (2012) Marcelo O Dietrich et al. NATURE NEUROSCIENCE
- The Opioid System and Food Intake: Homeostatic and Hedonic Mechanisms
- (2012) Ruben Nogueiras et al. Obesity Facts
- Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
- (2011) W Timothy Garvey et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- NPY receptors as potential targets for anti-obesity drug development
- (2011) Ernie Yulyaningsih et al. BRITISH JOURNAL OF PHARMACOLOGY
- Intracellular Signals Mediating the Food Intake-Suppressive Effects of Hindbrain Glucagon-like Peptide-1 Receptor Activation
- (2011) Matthew R. Hayes et al. Cell Metabolism
- Rapid Tachyphylaxis of the Glucagon-Like Peptide 1-Induced Deceleration of Gastric Emptying in Humans
- (2011) M. A. Nauck et al. DIABETES
- A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes
- (2011) P. Barrington et al. DIABETES OBESITY & METABOLISM
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
- (2011) David B. Allison et al. Obesity
- Pharmacokinetics and Pharmacodynamics of Exenatide Extended-Release After Single and Multiple Dosing
- (2010) Mark Fineman et al. CLINICAL PHARMACOKINETICS
- Central and Peripheral Molecular Targets for Antiobesity Pharmacotherapy
- (2010) M A Valentino et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Lorcaserin, A 5-HT2CReceptor Agonist, Reduces Body Weight by Decreasing Energy Intake without Influencing Energy Expenditure
- (2010) Corby K. Martin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- The metabolic actions of glucagon revisited
- (2010) Kirk M. Habegger et al. Nature Reviews Endocrinology
- Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
- (2010) Steven R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- (2010) W. Philip T. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of PTP1B by Trodusquemine (MSI-1436) Causes Fat-specific Weight Loss in Diet-induced Obese Mice
- (2010) Kristen A. Lantz et al. Obesity
- The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior
- (2010) P.A. Randall et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Brain serotonin system in the coordination of food intake and body weight
- (2010) Daniel D. Lam et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Potent and Selective Agonism of the Melanocortin Receptor 4 With MK-0493 Does Not Induce Weight Loss in Obese Human Subjects: Energy Intake Predicts Lack of Weight Loss Efficacy
- (2009) R Krishna et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
- (2009) A. Pocai et al. DIABETES
- Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjects
- (2009) M. A. Bush et al. DIABETES OBESITY & METABOLISM
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
- (2009) John B Buse et al. LANCET
- Metabolic Syndrome and Cancer
- (2009) Pooja Pothiwala et al. Metabolic Syndrome and Related Disorders
- A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
- (2009) Jonathan W Day et al. Nature Chemical Biology
- ‘Liking’ and ‘wanting’ food rewards: Brain substrates and roles in eating disorders
- (2009) Kent C. Berridge PHYSIOLOGY & BEHAVIOR
- America’s First Amphetamine Epidemic 1929–1971
- (2008) Nicolas Rasmussen AMERICAN JOURNAL OF PUBLIC HEALTH
- Ghrelin Modulates Brain Activity in Areas that Control Appetitive Behavior
- (2008) Saima Malik et al. Cell Metabolism
- Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas
- (2008) J. de Heer et al. DIABETOLOGIA
- Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial
- (2008) Arne Astrup et al. LANCET
- Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
- (2008) Daniel J Drucker et al. LANCET
- 5-HT2CRs Expressed by Pro-Opiomelanocortin Neurons Regulate Energy Homeostasis
- (2008) Yong Xu et al. NEURON
- Modulation of Blood Pressure by Central Melanocortinergic Pathways
- (2008) Jerry R. Greenfield et al. NEW ENGLAND JOURNAL OF MEDICINE
- Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies
- (2008) J. D. Roth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes
- (2008) Helle Linnebjerg et al. REGULATORY PEPTIDES
- Mutations in ligands and receptors of the leptin–melanocortin pathway that lead to obesity
- (2008) I Sadaf Farooqi et al. Nature clinical practice. Endocrinology & metabolism
- Supraphysiological doses of intravenous PYY3-36 cause nausea, but no additional reduction in food intake
- (2008) Carel W le Roux et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Serotonin 5-HT2CReceptor Agonist Promotes Hypophagia via Downstream Activation of Melanocortin 4 Receptors
- (2007) Daniel D. Lam et al. ENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started